Complete Story
05/12/2022
AMDA - The Society for PALTC Medicine | May 11
COMMERCIAL: COVID-19 Update
Headlines:
Journal Articles/Preprints
- MMWR: Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
- JAMDA: Nurse-Physician Communication Around Identifying Palliative Care Needs in Nursing Home Residents
- JAMDA: Impact of COVID-19 on Structure and Function of Program of All-Inclusive Care for the Elderly (PACE) Sites in North Carolina
- Resident Mortality And Worker Infection Rates From COVID-19 Lower In Union Than Nonunion US Nursing Homes, 2020–21
- Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State–wide Psychiatric Hospital System
- COVID-19 Vaccination—Becoming Part of the New Normal
- Association between staff turnover and nursing home quality – evidence from payroll-based journal data
- MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial
Research Reports/White Papers
Podcasts/Webinars
- TODAY: FMDA's Journal Club | Long COVID – Clinical Deep Dive, May 11, 2022, 12:00 PM ET
- Caring On-The-Go, April 2022
- JAMDA On-The-Go, April 2022
News/News Analysis
- What Do We Know About Paxlovid Rebound?
- Staff turnover hurting nurse-physician communication, study finds
- Inside the Race to Certify Temporary Nurse Aides as End to Waiver Nears
- Assisted living communities in more danger of closing than nursing homes
- Latest COVID Subvariants Create New Waves, Evade Immunity
- White House documents detail a looming squeeze on Covid-19 boosters
- Hospital admission totals tick up after weeks of rising COVID-19 cases
- Evidence mounts for need to study Pfizer's Paxlovid for long COVID - researchers say